Supplier News

Jun 01, 2018
By BioPharm International Editors
TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.
Jun 01, 2018
By BioPharm International Editors
Lonza has added four liver cell types to its hepatocytes portfolio for testing of in vitro drug models.
May 30, 2018
By BioPharm International Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 29, 2018
By BioPharm International Editors
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.
May 24, 2018
By BioPharm International Editors
In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.
May 22, 2018
By BioPharm International Editors
The company has leased and purchased facilities in the United States and Europe to expand its cell therapy pipeline.
May 17, 2018
By BioPharm International Editors
The second phase of a $5.5-million expansion adds controlled-substance and controlled-temperature storage to Catalent clinical trials facility.
May 17, 2018
By BioPharm International Editors
Parker Bioscience will expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site.
May 16, 2018
By BioPharm International Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 16, 2018
By BioPharm International Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
native1_300x100
lorem ipsum